Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma

Chemotherapy is considered “state of the art” for the treatment of poorly differentiated neuroendocrine neoplasms. Unfortunately, there is no standard effective post-first-line treatment for relapsing high-grade gastroenteropancreatic neuroendocrine neoplasms. We report the case of a patient with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Maria João Marques, Alonso, Teresa, Gajate, Pablo, Molina, Javier, Barquin, Arantzazu, Perna, Cristian, Grande, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: São Paulo, SP: Universidade de São Paulo, Hospital Universitário 2018
Materias:
Article / Clinical Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828287/
https://www.ncbi.nlm.nih.gov/pubmed/29515980
http://dx.doi.org/10.4322/acr.2018.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828287/
https://www.ncbi.nlm.nih.gov/pubmed/29515980
http://dx.doi.org/10.4322/acr.2018.005

Ejemplares similares